Ivan Oransky
π€ PersonAppearances Over Time
Podcast Appearances
So, and I would just, not so much as a correction, but just to say that, yes, Mark Tessier-Levine was defenestrated as president. He remains, at least at the time of this discussion, a tenured professor at Stanford, which is a pretty nice position to be in.
So, and I would just, not so much as a correction, but just to say that, yes, Mark Tessier-Levine was defenestrated as president. He remains, at least at the time of this discussion, a tenured professor at Stanford, which is a pretty nice position to be in.
So, and I would just, not so much as a correction, but just to say that, yes, Mark Tessier-Levine was defenestrated as president. He remains, at least at the time of this discussion, a tenured professor at Stanford, which is a pretty nice position to be in.
I've been quoted saying that the most likely career path or the most likely outcome for anyone who has committed misconduct is a long and fruitful career. And I mean that because it's true. Because most people, if they're caught at all, they skate. The number of cases we write about, which, you know, grows every year, but is still a tiny fraction of what's really going on.
I've been quoted saying that the most likely career path or the most likely outcome for anyone who has committed misconduct is a long and fruitful career. And I mean that because it's true. Because most people, if they're caught at all, they skate. The number of cases we write about, which, you know, grows every year, but is still a tiny fraction of what's really going on.
I've been quoted saying that the most likely career path or the most likely outcome for anyone who has committed misconduct is a long and fruitful career. And I mean that because it's true. Because most people, if they're caught at all, they skate. The number of cases we write about, which, you know, grows every year, but is still a tiny fraction of what's really going on.
Dan Ariely, we interviewed Dan years ago about some questions in his research. Duke is actually, I would argue, a little bit of a singular case. really bad, significant misconduct.
Dan Ariely, we interviewed Dan years ago about some questions in his research. Duke is actually, I would argue, a little bit of a singular case. really bad, significant misconduct.
Dan Ariely, we interviewed Dan years ago about some questions in his research. Duke is actually, I would argue, a little bit of a singular case. really bad, significant misconduct.
So I got to be honest, and, you know, people in Durham may not like me saying this, but I think Duke has a lot of work to do to demonstrate that their investigations are complete and that they are doing the right thing by research dollars and for patients.
So I got to be honest, and, you know, people in Durham may not like me saying this, but I think Duke has a lot of work to do to demonstrate that their investigations are complete and that they are doing the right thing by research dollars and for patients.
So I got to be honest, and, you know, people in Durham may not like me saying this, but I think Duke has a lot of work to do to demonstrate that their investigations are complete and that they are doing the right thing by research dollars and for patients.
People are now really fixated on what are known as paper mills. So if you think about the economics of this, rightβ It is worthwhile if you are a researcher to actually pay. In other words, it's an investment in your own future to pay to publish a certain paper. What I'm talking about is literally buying a paper or buying authorship on a paper.
People are now really fixated on what are known as paper mills. So if you think about the economics of this, rightβ It is worthwhile if you are a researcher to actually pay. In other words, it's an investment in your own future to pay to publish a certain paper. What I'm talking about is literally buying a paper or buying authorship on a paper.
People are now really fixated on what are known as paper mills. So if you think about the economics of this, rightβ It is worthwhile if you are a researcher to actually pay. In other words, it's an investment in your own future to pay to publish a certain paper. What I'm talking about is literally buying a paper or buying authorship on a paper.
So to give you a little bit of a sense of how this might work, You're a researcher who is about to publish a paper. So, you know, doesn't it at all have got, you know, some interesting finding that you've actually written up and a journal has accepted. It's gone through peer review. And you're like, great. And that's good for you.
So to give you a little bit of a sense of how this might work, You're a researcher who is about to publish a paper. So, you know, doesn't it at all have got, you know, some interesting finding that you've actually written up and a journal has accepted. It's gone through peer review. And you're like, great. And that's good for you.
So to give you a little bit of a sense of how this might work, You're a researcher who is about to publish a paper. So, you know, doesn't it at all have got, you know, some interesting finding that you've actually written up and a journal has accepted. It's gone through peer review. And you're like, great. And that's good for you.
But you actually also want to make a little extra money on the side. So you take that paper that essentially it's not a paper. It's really still a manuscript. You put it up on a brokerage site or you put the title up on a brokerage site. You say, I've got a paper where, you know, there are four authors right now.
But you actually also want to make a little extra money on the side. So you take that paper that essentially it's not a paper. It's really still a manuscript. You put it up on a brokerage site or you put the title up on a brokerage site. You say, I've got a paper where, you know, there are four authors right now.